Playbook
How to Build Commercially-Viable Devices at Scale
Innovating in medtech takes more than building something new. You need to build something better — viable, scalable, and clinically meaningful.
Key Lessons from this Playbook
Balance innovation with industry standards: Investing in in-house capabilities helps you test, learn, iterate, and scale more efficiently when bringing new technology to market. Own what gives you an edge, but know when to follow the playbook to keep things moving.
Minimize risk, maximize traction: For a lower-risk path, focus on building the next-generation device in an existing therapy space with a clear unmet need. Tackle clinical and technical risks one step at a time. At every stage, demonstrate measurable progress.
The best products don’t just work — they evolve: A product launch isn’t the finish line. Real-world use will expose gaps that bench tests can’t predict. Build with flexibility in mind — whether it’s designing for serviceability, efficient scaling, or adaptability across markets.
Build from the problem, not the tech: Design from the problem outward. Start with a real clinical need, not just a clever technology. Test in real-world conditions early, not just idealized lab settings. Unexpected challenges often reveal new data and opportunities.
Don’t rush into investment — or commercialization: Focus first on proving your technology. Validate rigorously, build credibility, and bring in investors only when you're ready to scale — not before.
